Somagen Obtains Patent for Molecular Identifier Characterizing Single Molecule Order Sequencing and Nucleic Acid Base Sequence Features
[Asia Economy Reporter Minwoo Lee] SomaGen announced on the 6th that it has obtained a European registered patent titled 'Unique Molecular Identifier for Single Molecule Sequencing and Characterization of Nucleic Acid Sequences.'
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
The company explained, "This patent pertains to the development of a target sequencing method using single molecule base sequencing technology and specific molecular markers (UMI)." It added, "By integrating with multiplex sequencing technology, it can accurately measure specific microbial markers, genomic variations, or RNA expression levels, thereby expanding its application to areas such as diagnosis of conditions including diseases related to microbes and genetic diagnostics in the future."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
